Parallel increase of subclinical atherosclerosis and epicardial adipose tissue in patients with HIV

American Heart Journal

Volumn 163, Issue 6, 2012, Pages 1024-1030

  Zona, Stefano ^a   Raggi, Paolo ^b   Bagni, Pietro ^a   Orlando, Gabriella ^a   Carli, Federica ^a   Ligabue, Guido ^a   Scaglioni, Riccardo ^a   Rossi, Rosario ^a   Modena, Maria Grazia ^a   Guaraldi, Giovanni ^a  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPOSE TISSUE; ADULT; ANTIVIRAL THERAPY; ARTICLE; ASYMPTOMATIC DISEASE; CARDIOVASCULAR PARAMETERS; CARDIOVASCULAR RISK; CD4+ T LYMPHOCYTE; CLINICAL TRIAL; COHORT ANALYSIS; COMPUTER ASSISTED TOMOGRAPHY; CONFIDENCE INTERVAL; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY CALCIFICATION; DISEASE COURSE; EPICARDIUM; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE LINEAR REGRESSION ANALYSIS; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROGNOSIS; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; SEX DIFFERENCE; THORAX RADIOGRAPHY;

ADIPOSE TISSUE; ADIPOSITY; ANTI-RETROVIRAL AGENTS; COMORBIDITY; CORONARY ARTERY DISEASE; CORONARY VESSELS; CYTOKINES; FEMALE; HIV INFECTIONS; HUMANS; LOGISTIC MODELS; MALE; PERICARDIUM; PROSPECTIVE STUDIES; RISK ASSESSMENT; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84862586176     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2012.03.019     Document Type: Article

References (33)

1. Carr A, Miller J, Law M, et al. A syndrome of lipoatrophy, lactic acidaemia and liver dysfunction associated with HIV nucleoside analogue therapy: contribution to protease inhibitor-related lipodystrophy syndrome. AIDS 2000;14:F25-32. (Pubitemid 30132938)
2. Carr A, Samaras K, Burton S, et al. A syndrome of peripheral lipodystrophy, hyperlipidaemia and insulin resistance in patients receiving HIV protease inhibitors. AIDS 1998;12:F51-8. (Pubitemid 28190689)
3. Grunfeld C, Saag M, Cofrancesco Jr J, et al. Regional adipose tissue measured by MRI over 5 years in HIV-infected and control participants indicates persistence of HIV-associated lipoatrophy. AIDS 2010;24:1717-26.
4. Despres JP, Ross R, Boka G, et al. Effect of rimonabant on the hightriglyceride/low-HDL-cholesterol dyslipidemia, intraabdominal adiposity, and liver fat: the ADAGIO-Lipids trial. Arterioscler Thromb Vasc Biol 2009;29:416-23.
5. Robicsek F, Thubrikar MJ. The freedom from atherosclerosis of intramyocardial coronary arteries: reduction of mural stress-a key factor. Eur J Cardiothorac Surg 1994;8:228-35.
6. Ishii T, Asuwa N, Masuda S, et al. The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol 1998;185:4-9. (Pubitemid 28266710)
7. Eroglu S, Sade LE, Yildirir A, et al. Epicardial adipose tissue thickness by echocardiography is a marker for the presence and severity of coronary artery disease. Nutr Metab Cardiovasc Dis 2009;19:211-7.
8. Gorter PM, de Vos AM, van der Graaf Y, et al. Relation of epicardial and pericoronary fat to coronary atherosclerosis and coronary artery calcium in patients undergoing coronary angiography. Am J Cardiol 2008;102:380-5.
9. Lo J, Abbara S, Rocha-Filho JA, et al. Increased epicardial adipose tissue volume in HIV-infected men and relationships to body composition and metabolic parameters. AIDS 2010;24:2127-30.
10. Agatston AS, Janowitz WR, Hildner FJ, et al. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990;15:827-32. (Pubitemid 20101575)
11. Budoff M, Shaw L, Liu S, et al. Long-term prognosis associated with coronary calcification: observations from a registry of 25,253 patients. J Am Coll Cardiol 2007;49:1860-70. (Pubitemid 46661110)
12. Raggi P, Callister T, Shaw L. Progression of coronary artery calcium and risk of first myocardial infarction in patients receiving cholesterollowering therapy. Arterioscler Thromb Vasc Biol 2004;24:1272-7. (Pubitemid 38880020)
13. Mangili A, Gerrior J, Tang A, et al. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score. Clin Infect Dis 2006;43:1482-9. (Pubitemid 44845654)
14. Lo J, Abbara S, Shturman L, et al. Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men. AIDS 2009;24:243-53.
15. From the Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. JAMA 1993;269:729-30.
16. Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III). JAMA 2001;285:2486-97.
17. Lichtenstein KA, Ward DJ, Moorman AC, et al. Clinical assessment of HIV-associated lipodystrophy in an ambulatory population. AIDS 2001;15:1389-98. (Pubitemid 32662290)
18. Yoshizumi T, Nakamura T, Yamane M, et al. Abdominal fat: standardized technique for measurement at CT. Radiology 1999;211:283-6. (Pubitemid 29161765)
19. Budoff M, Nasir K, McClelland R, et al. Coronary calcium predicts events better with absolute calcium scores than age-sex-race/ethnicity percentiles: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Coll Cardiol 2009;53:345-52.
20. Budoff MJ, Hokanson JE, Nasir K, et al. Progression of coronary artery calcium predicts all-cause mortality. JACC Cardiovasc Imaging 2010;3:1229-36.
21. Gorter PM, van Lindert AS, de Vos AM, et al. Quantification of epicardial and peri-coronary fat using cardiac computed tomography; reproducibility and relation with obesity and metabolic syndrome in patients suspected of coronary artery disease. Atherosclerosis 2008;197:896-903. (Pubitemid 351417890)
22. Nichols JH, Samy B, Nasir K, et al. Volumetric measurement of pericardial adipose tissue from contrast-enhanced coronary computed tomography angiography: a reproducibility study. J Cardiovasc Comput Tomogr 2008;2:288-95.
23. Deeks SG. Immune dysfunction, inflammation, and accelerated aging in patients on antiretroviral therapy. Top HIV Med 2009;17:118-23.
24. Cani PD, Amar J, Iglesias MA, et al. Metabolic endotoxemia initiates obesity and insulin resistance. Diabetes 2007;56:1761-72. (Pubitemid 47025442)
25. Wu H, Ghosh S, Perrard XD, et al. T-cell accumulation and regulated on activation, normal T cell expressed and secreted upregulation in adipose tissue in obesity. Circulation 2007;115:1029-38. (Pubitemid 46328297)
26. Duffaut C, Zakaroff-Girard A, Bourlier V, et al. Interplay between human adipocytes and T lymphocytes in obesity: CCL20 as an adipochemokine and T lymphocytes as lipogenic modulators. Arterioscler Thromb Vasc Biol 2009;29:1608-14.
27. Hunt PW, Martin JN, Sinclair E, et al. T cell activation is associated with lower CD4+ T cell gains in human immunodeficiency virusinfected patients with sustained viral suppression during antiretroviral therapy. J Infect Dis 2003;187:1534-43. (Pubitemid 36578959)
28. Kaplan RC, Sinclair E, Landay AL, et al. T cell activation and senescence predict subclinical carotid artery disease in HIV-infected women. J Infect Dis 2011;203:452-63.
29. Andersson J, Libby P, Hansson GK. Adaptive immunity and atherosclerosis. Clin Immunol 2010;134:33-46.
30. + T-cell count as a major atherosclerosis risk factor in HIV-infected women and men. AIDS 2008;22:1615-24.
31. Guaraldi G, Scaglioni R, Zona S, et al. Epicardial adipose tissue is an independent marker of cardiovascular risk in HIV-infected patients. AIDS 2011;25:1199-205.
32. Iacobellis G, Singh N, Wharton S, et al. Substantial changes in epicardial fat thickness after weight loss in severely obese subjects. Obesity (Silver Spring) 2008;16:1693-7. (Pubitemid 351915121)
33. Falutz J, Allas S, Blot K, et al. Metabolic effects of a growth hormonereleasing factor in patients with HIV. N Engl J Med 2007;357:2359-70. (Pubitemid 350223390)